Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGREE: Colchicine Dose Comparison in Acute Gout Flare
NCT00506883Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2007
- Primary completion
- Oct 2007
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in gout, sponsored by Takeda. Started Apr 2007; status: completed.
02
Drugs
colchicine
03
Conditions
gout
Beyond the preview
Go deeper on NCT00506883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506883.